Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Screening for malignant melanoma: A cost-effectiveness analysis.

K A Freedberg1, A C Geller, D R Miller

  • 1Clinical Economics Research Unit, Section of General Internal Medicine, Department of Medicine and Evans Medical Foundation, Boston Medical Center, Boston University School of Medicine, Massachusetts 02118-2393, USA.

Journal of the American Academy of Dermatology
|October 27, 1999
PubMed
Summary

Skin cancer screening for high-risk individuals offers a small increase in life expectancy and is cost-effective. Early melanoma detection through visual screening improves outcomes and is comparable to other cancer screenings.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A review of nevus-associated melanoma: What is the evidence?

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Not all melanomas are created equal: a review and call for more research into nodular melanoma.

The British journal of dermatology·2021
Same author

A multicentre study of naevus-associated melanoma vs. de novo melanoma, tumour thickness and body site differences.

The British journal of dermatology·2021
Same author

Role of the partner/spouse in melanoma discovery and related health behaviours and practices.

The British journal of dermatology·2019
Same author

Psychosocial impact of skin biopsies in the setting of melanoma screening: a cross-sectional survey.

The British journal of dermatology·2018
Same author

The impact of dermoscopy on melanoma detection in the practice of dermatologists in Europe: results of a pan-European survey.

Journal of the European Academy of Dermatology and Venereology : JEADV·2017

Area of Science:

  • Dermatology and Public Health
  • Cancer Screening and Prevention
  • Health Economics

Background:

  • Skin cancer is the most prevalent cancer in the U.S.
  • Malignant melanoma screening shows effectiveness, but cost-effectiveness data is lacking.
  • High-risk populations require targeted screening strategies.

Purpose of the Study:

  • To evaluate the effectiveness and cost-effectiveness of visual screening for diagnosing malignant melanoma in high-risk individuals.
  • To compare outcomes and costs of a single dermatological screen versus no screening.
  • To inform public health policy regarding skin cancer screening protocols.

Main Methods:

  • Decision analysis model comparing screening versus no screening.
  • Inclusion of clinical outcomes: malignant melanoma, nonmelanoma skin cancer, or no cancer.

Related Experiment Videos

  • Projection of life expectancy and healthcare costs based on clinical data.

    • Main Results:

    • Screening increased average life expectancy by 0.0012 years per person.
    • For every person diagnosed with melanoma, life expectancy increased by 0.9231 years.
    • The incremental cost-effectiveness ratio was $29,170 per year of life saved (YLS) with screening.
    • Screening remained cost-effective (below $50,000/YLS) under various sensitivity analyses, including prevalence, detection rates, and screening costs.

    Conclusions:

    • Skin cancer screening in high-risk patients yields a modest increase in life expectancy.
    • The cost-effectiveness of screening is reasonable when compared to other cancer screening programs.
    • Visual screening by dermatologists is a viable strategy for early malignant melanoma detection.